Nurix Therapeutics, Inc.
Recent Filings
All 486 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 27, 2026 |
| ARS | ARS | Mar 27, 2026 |
| DEFA14A | DEFA14A | Mar 27, 2026 |
| DEF 14A | DEF 14A | Mar 27, 2026 |
| 8-K | 8-K | Mar 6, 2026 |
| 424B5 | 424B5 | Mar 6, 2026 |
| 4 | FORM 4 | Mar 2, 2026 |
| 144 | — | Mar 2, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| 4 | FORM 4 | Feb 10, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| van Houte Hans | Chief Financial Officer | Sale | 6,284 @ $12.56 | 37,592 | Nov 3, 2025 |
| van Houte Hans | Chief Financial Officer | Sale | 5,402 @ $11.03 | 35,512 | Aug 1, 2025 |
| Hansen Gwenn | Chief Scientific Officer | Sale | 4,308 @ $12.01 | 69,023 | Jul 30, 2025 |
| van Houte Hans | Chief Financial Officer | Sale | 6,198 @ $11.33 | 33,724 | May 2, 2025 |
| van Houte Hans | Chief Financial Officer | Sale | 2,438 @ $11.50 | 39,922 | Apr 30, 2025 |
| van Houte Hans | Chief Financial Officer | Sale | 5,125 @ $14.40 | 34,424 | Mar 3, 2025 |
| Ring Christine | Chief Legal Officer | Sale | 2,929 @ $19.81 | 32,829 | Jan 30, 2025 |
| Ring Christine | Chief Legal Officer | Sale | 5,760 @ $19.50 | 28,084 | Jan 2, 2025 |
| van Houte Hans | Chief Financial Officer | Sale | 3,546 @ $24.28 | 33,724 | Nov 1, 2024 |
| Ring Christine | Chief Legal Officer | Sale | 300 @ $22.81 | 24,592 | Oct 1, 2024 |